We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pharmaceutical firm Allergan, maker of the antiwrinkle treatment Botox, has offered roughly $3.2 billion to buy cosmetic device manufacturer Inamed — a proposal that comes as Inamed already is in merger talks with dermatology products firm Medicis Pharmaceutical.
Impax Laboratories has signed a supply and distribution deal under which DAVA Pharmaceuticals will market Impax’s oxycodone HCl extended-release tablets in the U.S. and Puerto Rico.
Indian drugmaker Dr. Reddy’s has expanded its presence in North America, agreeing to purchase Roche’s active pharmaceutical ingredient (API) business in Mexico.
Tamiflu’s price is significantly higher for non-pandemic use, with Roche charging between 20 euros and 51 euros ($23.54-$60.00) for one course of treatment.
The FTC is suing Barr Laboratories and Warner Chilcott, seeking to nullify a $20 million agreement to keep a generic version of Warner’s contraceptive Ovcon-35 off the market — a move that shows the FTC is taking a stronger stance against what it sees as anticompetitive deals within the drug industry, one analyst says.
Indian drugmaker Dr. Reddy's has expanded its presence in North America, agreeing to purchase Roche's active pharmaceutical ingredient (API) business in Mexico.
IMPAX Laboratories has signed a supply and distribution deal under which DAVA Pharmaceuticals will market IMPAX's oxycodone HCl extended-release tablets in the U.S. and Puerto Rico.
Wyeth plans to phase out its Rouses Point, N.Y., manufacturing operation over the next three years — a move prompted by slumping sales of the company’s hormone-replacement drug Premarin, which is made at the plant.